SS
Samir Suresh Joshi
About Samir Suresh Joshi
Data last updated:
Samir Suresh Joshi is a Designated Partner at Miraj Nuclear Medicine And Molecular Imaging Center Llp (since 2017) and Designated Partner at Sclass Pharmaceuticals Llp (since 2022). The companies operate in Healthcare and Home Appliances. The largest current company by reported revenue is Miraj Nuclear Medicine And Molecular Imaging Center Llp at ₹91.3 Lakh (FY 2023). Earlier, Samir Suresh Joshi was a Director at Jyplus Joyel Pharma Private Limited (from 2022).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Designated Partner | 29 Mar 2017 | 2017 | ₹91.3 Lakh (FY 2023) | Active | |
 Sclass Pharmaceuticals Llp ABC-1364 | Designated Partner | 19 Aug 2022 | 2022 | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Jyplus Joyel Pharma Private Limited U24290PN2022PTC215135 | Director | 29 Sep 2022 | 2022 | Strike Off |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Samir Suresh Joshi
| Name | DIN | Company | Designation |
|---|---|---|---|
| Aniket Manohar Inamdar | 09705622 | Miraj Nuclear Medicine And Molecular Imaging Center Llp | Partner |
| Apurva Sudhir Shah | 01625573 | Miraj Nuclear Medicine And Molecular Imaging Center Llp | Partner |
| Kalpesh Kiran Shah | 07757984 | Miraj Nuclear Medicine And Molecular Imaging Center Llp | Designated Partner |
| Sandeep Bhogilal Shah | 02350692 | Miraj Nuclear Medicine And Molecular Imaging Center Llp | Partner |
| Abhijeet Laxman Yelkar | 10016130 | Sclass Pharmaceuticals Llp | Designated Partner |
| Shashank Joshi Sureshrao | 05332369 | Sclass Pharmaceuticals Llp | Designated Partner |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Samir Suresh Joshi
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Samir Suresh Joshi
Samir Suresh Joshi currently holds 2 directorships: Miraj Nuclear Medicine And Molecular Imaging Center Llp (Designated Partner, since 29 Mar 2017, revenue ₹91.3 Lakh (FY 2023)); Sclass Pharmaceuticals Llp (Designated Partner, since 19 Aug 2022).
Samir Suresh Joshi was first appointed on 29 Mar 2017 as Designated Partner at Miraj Nuclear Medicine And Molecular Imaging Center Llp. The most recent appointment on record is 29 Sep 2022 at Jyplus Joyel Pharma Private Limited.
Samir Suresh Joshi held 1 earlier board appointment: Jyplus Joyel Pharma Private Limited (Director, from 29 Sep 2022).
The current boards of Samir Suresh Joshi's companies include Aniket Manohar Inamdar (Miraj Nuclear Medicine And Molecular Imaging Center Llp), Apurva Sudhir Shah (Miraj Nuclear Medicine And Molecular Imaging Center Llp), Kalpesh Kiran Shah (Miraj Nuclear Medicine And Molecular Imaging Center Llp), Sandeep Bhogilal Shah (Miraj Nuclear Medicine And Molecular Imaging Center Llp), Abhijeet Laxman Yelkar (Sclass Pharmaceuticals Llp), Shashank Joshi Sureshrao (Sclass Pharmaceuticals Llp).